Burow Kristina's Form 4 filing
Neumora Therapeutics, Inc. (NMRA) · filed Nov 15, 2023
- Accession no.
- 0001062993-23-020934
- Filed
- Nov 15, 2023
- Trade date
- Nov 13-14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $412.1K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Burow KristinaCIK 0001569248 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 13, 2023 | Common Stock | PPurchaseAcquired | +31,653 | $11.75 | +$371,922.75 | 4,127,850 | Indirect | |
| Nov 14, 2023 | Common Stock | PPurchaseAcquired | +3,357 | $11.98 | +$40,216.86 | 4,131,207 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.